Emergence of Erythromycin-Resistant Invasive Group A Streptococcus, West Virginia, USA, 2020–2021

Emergence of Erythromycin-Resistant Invasive Group A Streptococcus, West Virginia, USA, 2020–2021

Clindamycin and β-lactam antibiotics have been mainstays for treating invasive group A Streptococcus (iGAS) infection, yet such regimens might be limited for strains displaying MLSB phenotypes. We investigated 76 iGAS isolates from 66 patients in West Virginia, USA, during 2020–2021. We performed e...

Full description

Bibliographic Details
Main Authors: Lillie M. Powell, Soo Jeon Choi, Chloe E. Chipman, Megan E. Grund, P. Rocco LaSala, Slawomir Lukomski
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2023-05-01
Series:Emerging Infectious Diseases
Subjects:
invasive group A Streptococcus
antimicrobial resistance
streptococci
Streptococcus pyogenes
erythromycin
clindamycin
Online Access:https://wwwnc.cdc.gov/eid/article/29/5/22-1421_article

Internet

https://wwwnc.cdc.gov/eid/article/29/5/22-1421_article

Similar Items